Targeting ion channels for cancer therapy by repurposing the approved drugs

Vijay Pralhad Kale, Shantu G. Amin, Manoj K. Pandey

Research output: Contribution to journalReview articlepeer-review

69 Scopus citations


Ion channels have been shown to be involved in oncogenesis and efforts are being poured in to target the ion channels. There are many clinically approved drugs with ion channels as "off" targets. The question is, can these drugs be repurposed to inhibit ion channels for cancer treatment? Repurposing of drugs will not only save investors' money but also result in safer drugs for cancer patients. Advanced bioinformatics techniques and availability of a plethora of open access data on FDA approved drugs for various indications and omics data of large number of cancer types give a ray of hope to look for possibility of repurposing those drugs for cancer treatment. This article is part of a Special Issue entitled: Membrane channels and transporters in cancers.

Original languageEnglish (US)
Article number81871
Pages (from-to)2747-2755
Number of pages9
JournalBiochimica et Biophysica Acta - Biomembranes
Issue number10
StatePublished - Oct 1 2015

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Cell Biology


Dive into the research topics of 'Targeting ion channels for cancer therapy by repurposing the approved drugs'. Together they form a unique fingerprint.

Cite this